National multicenter study of eligibility for interferon and ribavirin therapy in patients coinfected with HIV and hepatitis C

被引：0
|
作者：
Bini, EJ
Currie, S
Shen, H
Brau, N
Schmidt, W
Wright, TL
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [1] Interferon-α and ribavirin combination therapy for hepatitis C in HIV-coinfected patients
    Rockstroh, JK
    Klausen, G
    Gölz, J
    Dupke, S
    Stein, L
    Notheis, G
    Stoehr, A
    Pascucci, GR
    Wasmuth, JC
    Mauss, S
    AIDS, 2000, 14 : S123 - S123
  • [2] Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients
    Benatti, Simone Vasilij
    Quinzan, Giampaolo
    Bigoni, Sara
    Rizzi, Marco
    Ripamonti, Diego
    AIDS, 2014, 28 (17) : 2633 - 2635
  • [3] Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?
    John McHutchison
    Amany Zekry
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 70 - 71
  • [4] Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?
    McHutchison, John
    Zekry, Amany
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 70 - 71
  • [5] Insulin Resistance Impairs Response to Interferon Plus Ribavirin in Patients Coinfected With HIV and Hepatitis C Virus
    Ryan, Pablo
    Resino, Salvador
    Miralles, Pilar
    Cosin, Jaime
    Carlos Lopez, Juan
    Moreno, Silvia
    Catalan, Pilar
    Ramirez, Margarita
    Gutierrez, Isabel
    Berenguer, Juan
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (02) : 176 - 181
  • [6] Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
    Medrano, Jose
    Neukam, Karin
    Rallon, Norma
    Rivero, Antonio
    Resino, Salvador
    Naggie, Susanna
    Caruz, Antonio
    Calvino, Aida
    Macias, Juan
    Miguel Benito, Jose
    Sanchez-Piedra, Carlos
    Vispo, Eugenia
    Barreiro, Pablo
    McHutchison, John
    Antonio Pineda, Juan
    Soriano, Vincent
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (10) : 1209 - 1216
  • [7] Chronic hepatitis C in HIV-infected patients:: Low eligibility and applicability of therapy with pegylated interferon-α plus ribavirin
    Rauch, A
    Egger, M
    Reichen, J
    Furrer, H
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (02) : 238 - 240
  • [8] Treatment of chronic hepatitis B/C coinfected patients with consensus interferon/ribavirin/lamivudine triple therapy
    Kaiser, S
    Hass, HG
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
  • [9] Interferon therapy in patients coinfected with hepatitis C (HCV) and human immunodeficiency virus (HIV).
    Venkataramani, A
    Rond, R
    Beaumont, C
    Lyche, K
    HEPATOLOGY, 1997, 26 (04) : 738 - 738
  • [10] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
12345